For today only...
Get Equitymaster's
Best Performing Research
For Rs  2,450  499 only

And Access Our Last
5 Buy Recommendations Immediately!


Dear Reader,

For today (and today only!), you can try our best performing research service at a price you've never heard before...

And at our Lowest price ever!

Just Rs 499!

And there's more...

If you act right away, you will also get immediate access to our latest 5 Buy recommendations.

Plus you will also have an opportunity to lock-in your subscription to one of our most popular stock recommendation services at its Lowest Price Ever!

All this as a thank you from us for trying our best performing research service.

Why are we doing this?

Because we really want you to make money. Safely. WITHOUT ANY RISKS.

And hence this offer:

Try our best performing research service StockSelect at Rs 499 for 3 months, and discover for yourself a simple and consistent way of making money.

And by making money, I'm talking here about returns like 251%, 302% and 156% in just two to three years!

How?

Just give me the next 7 minutes of your time, and I'll show you exactly how StockSelect could help you multiply your money. SAFELY.

You see, over the years we've seen people take way too much risk in order to make money - they rely on hot tips, rumours, or advice from friends and brokers. And often end up buying stocks which turn out to be 'duds'.

With StockSelect, you'll be able to invest in financially sound companies, with huge growth potential.

In fact, by following our recommendations, our StockSelect subscribers have already made double and triple-digit returns like

Company Name Returns (%)
GSK Consumer 302% in 34 months
Dr. Reddy's 120% in 32 months
Aventis Pharma 84% in 13 months
Tata Steel 156% in 39 months
Maruti Suzuki 86% in 5 months

And here's what a few of them have to say:

"I realized the value of fundamentals only after I started using Equitymaster"

"I am a subscriber to these services for the past five years. I realized the value of fundamentals for investment decisions only after I started using the services of equitymaster.com.Earlier, my decisions used to be based on "tips" or "advice from friends" etc.; Equitymaster taught me to base them on business fundamentals. One very good quality of your organization is that I never have even 5% of doubt about your unbiased approach and your integrity to the retail investors. Overall, I value the services offered by Equitymaster.com and I acknowledge their contribution to make my investment decisions more scientific."

-- Satish Pendse, a StockSelect Subscriber since 2003


"I believe I have bought peace to myself"

"I have been following and investing in the markets for 9 years. I would follow all the hot "tips" coming out of the horse's mouth only to see my capital erode. But ever since i have bought Equitymaster products, I BELIEVE I HAVE BOUGHT PEACE TO MYSELF. Trust me these days, I feel more happier when the stock market crashes, as I know I am buying into companies that are researched as "Fundamentally & Technically Strong".

To summarise "Sleeping pills are cheap... but they come with a habit... whereas meditation is difficult but it develops a positive attitude".... Equitymaster thou next name is Meditation."

-- Eisen Philip, Lifetime subscriber

So why is StockSelect so popular?

The reason is its consistent performance -- both during good times and bad, it has consistently helped its subscribers make double and triple-digit returns from the stock market's safest stocks.

And they did this without unnecessarily risking their life's saving.

Now, don't get me wrong here...

Whenever you invest in stocks, there's always a chance that you will lose money. That's an undeniable fact.
But what we help you do is minimize the risk of losing money. By simply picking well-managed companies that are available for dirt cheap.
Our subscribers who followed our recommendations had several safe money making opportunities literally knocking on their door, to double and triple their money.

In fact,as per the audited records, StockSelect has a success rate of 81.3%!

Now you don’t just have to take my word for it. Here’s how three of our recommendations have done in just the past few years -

1) GSK Consumer

GSK Consumer

We recommended GSK Consumer in February 2009 when the Indian malted beverage market was seeing stiff competition from new entrants like Dabur and Hindustan Unilever.

In the midst of all this, GSK initiated a 7% price hike in its flagship brand 'Horlicks'. It also leveraged its brand power to launch new variants.

This firmed up our confidence in the company retaining its 70% market share. Plans to introduce products from its global parent's portfolio in oral care, energy drink and other segments over the next 3 to 4 years was the additional sweetener.

So we maintained that despite competition GSK Consumer would be able to leverage its brand power to emerge stronger and improve returns to shareholders.

And we were proven right! The stock rose 302% till we recommended a Sell.

2) Bharat Forge

 Bharat Forge

We recommended this stock in April 2009. The company was then facing serious issue on the balance sheet front as it had loaded the same with debt.

Our view was that the company was soon to get a return on the expansion it made using this debt. We expected the company's domestic operations as well as foray into other segments to minimize the impact that sharply lower exports were having on its overall business.

While we agreed that the company was no doubt struggling to grow at rates that it has managed to do in the past, we thought the fall in stock price was much exaggerated.

And the stock shot up by 251% till we recommended a Sell.

3) Tata Steel

Tata Steel

We recommended Tata Steel in December 2008, when the stock was trading a mammoth 80% lower than its 52-week highs!

The stock's underperformance then could be attributed to its balance sheet that had been loaded with debt on account of the leveraged buyout of Corus.

While we saw the concerns as being valid, we knew those were far too exaggerated. Our calculations showed that even if the company's earnings were to fall by 50%, there would still be enough cash flow for it to pay for its financial expenses on the debt.

So we remained confident that the company will come out of the downturn rather unscathed.

And the stock is up 156% since then.

And while we are discussing our performers here, allow us to clarify that it's not like we do not make mistakes. We do! But, our winning recommendations more than make up for those mistakes.

Of all the stocks that we have recommended, 81.3% have hit their target prices within the specified time period and often, before.

That means for every 10 large caps stocks we recommend through StockSelect, 8 hit their target.

So there are 2 stocks out of every 10 that do not perform as expected.

Now, there's no doubt that we recommend a stock only when it meets all the required parameters.

But sometimes... despite having all those valid reasons for recommending the stocks... the assumptions we make turn out to be incorrect.

For example, We recommended IDFC and Voltas in 2010 and 2011 respectively, when the stocks seemed to be offering tremendous value given their industry leadership and strong long-term growth prospects. However, their stock prices showed no signs of strengthening, and in fact corrected further from the recommended levels.

Investors seemed to have lost interest in these sectors. And the lack of near term growth visibility coupled with policy inaction resulted in lower valuations for the stocks.

  Reco. Date Reco. Price Price as on 30th March 2012 Change
Voltas 25-Feb-11 158 112 -29%
IDFC 2-July-10 180 135 -25%

Now, we understand it is natural for investors to be anxious about the correction.

But we find no reason to change our view on the stocks given that both the policy hiccups and near term growth uncertainties are temporary in nature.

Both IDFC and Voltas are bound to keep their long term growth rates intact even if India's GDP grows at an average of 6.5% over the next 5 years.

The high margin of safety in their valuations could in fact help investors grab sound, good businesses at discounted prices.

But for Every Loss, There is
An Equally Powerful Winner. . .

The way the markets are, it's unrealistic to expect each and every recommendation to be a winner.

The idea is such that your Profits should more than make up for any loss that you may face. And in this respect, StockSelect excels...

Let's have a look at some of our star performers...

We recommended L&T on 5th November, 2002 when it was selling at Rs 48*. And when we gave a SELL on it in March of 2010, it had risen a whopping 3,311%.

Similarly, Voltas too, which we recommended on 30th June, 2003 returned 2,740% until August 2010 when we gave a SELL on it.

(*Recommendation prices have been adjusted for bonuses and stock splits over the years)

And we feel proud when our subscribers write back to us, appreciating all the hard work and the effort that we put in to identify such money making opportunities for you.

Here's what they have to say...

"It's been 5 years since I have been a subscriber to all the products of Equitymaster (EM).

EM's "power to people" approach is what made me to associate with them initially. EM's honest, independent and consistent research on stocks is worth appreciating.

In short, I must say it has been a "rewarding" experience."

-- S R Samratt, a StockSelect subscriber since 2005


"I am a much more patient, confident and richer investor. All credit to your SELFLESS and exceAllent research values and giving genuine recommendations!"

-- Nishank Mehta, A subscriber since 2009

A Quick Recap of the recommendations
that we have mentioned. . .


Name of the Stock Recommended   Returns Captured
GSK Consumer 302%
Bharat Forge 251%
Dr. Reddy's 120%
Aventis Pharma 84%
Tata Steel 156%
Maruti Suzuki 86%
L&T 3,311%
Voltas 2,740%

And the secret to picking out
SAFE Money-Making stocks is . . .

The Equitymaster Risk Matrix or The ERM.

The ERM is an integral part of our stock selection process. All the stocks that we even consider have to pass through this stringent tool called the ERM.

This Matrix helps us eliminate risky stocks and thus identify stocks with potential.

In 2008, when investors were hesitant to even touch stocks, we recommended a BUY on ACC, and Maruti Suzuki. These recommendations were backed by our confidence in the low risk profile of these companies as shown by ERM. As expected, these stocks went on to grow our subscribers' wealth several times.

And it was THIS risk matrix that helped us zero in on the best stocks when several of them were looking attractive. It did so by acting as one of the tools used for eliminating the bad stocks, so that we recommend only the good stocks to you.

And even THIS offer is entirely risk-free for you . . .

We are so confident of our research that we are offering a 30-Day, No-Questions-Asked, 100% Money Back Guarantee with StockSelect as part of this offer.

Now we know that it's difficult to just settle for somebody's word. All of us would rather prefer to experience these things ourselves than rely on hearsay.

And hence this 3 months trial offer comes with a 30 Days 100% Money Back guarantee.

Try our research. Go through all our archives. See our last 5 Buy recommendations (by the way, they still hold a lot of value about which I will tell you shortly)...

In short, try and test the product as much as you want.

If you still feel that StockSelect is not for you simply let us know before the 31st day and we will refund all your money – the entire Rs 499. No Questions Asked.

Plus you get our Last 5 Buy Recommendations . . .

As soon as you sign up for StockSelect, you can immediately access our last 5 Buy Recommendations and get a thorough, complete analysis on why we consider them investment worthy.

So read our investment rationale, have a look at the valuations of the company, know our views on the stock and decide if you want to go ahead and buy the stock or not.

While we obviously can't tell you about our last 5 Buy recommendations here, allow us to share the performance of some of our very recent Buy recommendations - These recommendations were given keeping an investment horizon of 2-3 years in mind.

Company Name Returns (%)
Exide Industries 37% in 24 months
Titan 45% in 3 months
SBI 20% in 5 months

And You Get A Gift Too: Our "Intelligent" Portfolio Tracker
Absolutely FREE!

Portfolio Tracker is Equitymaster's portfolio tracking utility. It's online, it's easy to use and is available to you 24 hrs a day.

It will not only help you manage your portfolio efficiently, but also help you grow your wealth!

Here are some of the amazing things you can do with this tool...
  • Track both- your mutual fund as well as equity portfolios in the same account

  • Get automatic end-of-week and end-of-month performance updates and alerts for the stocks and funds that you own and even for those that you simply wish to track

  • Plus track your SIPS and get NAV alerts for the mutual fund schemes
And what makes the Portfolio Tracker unique are the intelligent reports that come along with it.

These reports will give you in-depth information about your portfolio as well as a detailed analysis to help you invest like a smart fund manager.

The Portfolio Tracker usually costs Rs 330 for a year. But you will get it absolutely FREE with your StockSelect subscription.

So, to recap, as our StockSelect Subscriber, you will get...

Well researched recommendations

As a StockSelect subscriber, for the next 3 months, every Friday, you will get our detailed views and stock recommendations. Delivered right into your inbox.

So you will get -
  • Our Buy Recommendations on stocks you should immediately get your hands on

  • Our Hold Recommendations on stocks you should not let go off

  • And our Sell Recommendations on stocks you should not even touch with a bargepole!
"In 2007, Equitymaster was probably the only research house which will give most of HOLD or SELL recommendations rather than BUY reports and everyone knows what happened after that. I feel to be proud subscriber of equitymaster seeing again that you still are not afraid of giving the right opinion irrespective of market moods. Great Job!!!"

-- Deepak Aggarwal, a subscriber since 2007

And we will also tell you the target price for them - At what price you should buy and at what price you should sell.

Exclusive S-features

These are articles and reports that are available to our premium subscribers only. And we have 800 of them!

As you know, there are lots of factors influencing the stock price. And most of them need to be monitored regularly. So from time to time, we release instant reports and updates on various companies.

These articles include excerpts of management meetings, extracts of conference calls, updates on the happenings in a company and our personal views on it, and so on.

This is all "unadulterated" information and it will serve as a valuable input for your investment decision.

Quarterly Performance Reviews

Also, we don't just recommend some companies and forget about them.

At the end of each quarter we review all the stocks that we recommended during the six month period prior to that.

We provide subscribers our latest analysis on all those recommendations... and whether we maintain our views on them or have changed the same.

We illustrate in detail our reasons for maintaining the stance or change in stance, and finally summarize all of those into an easy to understand table.

stoctselect recommendations

Apart from these quarterly reviews, another thing that forms part of the "ongoing coverage" is the Quarterly Result Analysis that we write for all companies under coverage... wherein we also mention whether the results are in line with our estimates or not, and whether we maintain our view on the stock or not.

Given that the markets are likely to remain bumpy for some more time, this kind of information can come in very handy.

Here's what one subscriber had to say about our review reports...

"I appreciate your dedication in giving periodic reviews and outlook/current recommendations. This is a stand out feature in your basket!"

-- Srinivasan S, a StockSelect Subscriber since 2008

Unlimited Unrestricted Access to all our Archives and
Our Special Reports that could SAFELY multiply your money

As our subscriber, you will also get unrestricted access to all our past recommendations, S-features, Special Reports and Large Cap Research.

So even if you want to check up on past issues or recommendations, you will be able to do that pretty easily.

As a StockSelect Subscriber, you will receive special reports as and when we release them.

In addition to all this, if you act right away you will also get...

Free subscription to The Daily Reckoning

Now you can read what knowledgeable investors across the globe read every single day for global market analysis and investment ideas.

Yes, we are delighted to bring you 'The Daily Reckoning', a daily financial e-column by Bill Bonner, Publisher and Editor, and three-time New York Times best-selling author.

As one reader put it, Bill "makes more sense in one e-mail than a month of CNBC".

The Daily Reckoning is published every day in 3 languages from offices in 6 countries - US, UK, Australia, France, Germany, and South Africa.

And now, it's India's turn... and your turn to get it for FREE!

When you subscribe to StockSelect, you automatically get a free subscription to the Daily Reckoning too.

An Open Line with Us . . .

We always enjoy hearing from our subscribers and have an open line with them.

Our subscribers are always welcome to share any suggestions, comments or issues that they have about our services with us.

We are always continuously trying to upgrade our service and we try to incorporate as many of suggestions as possible to better the service.

In fact over the past one year, StockSelect has undergone quite a lot of change - to make it more user-friendly and even more profitable for our subscribers like you.

We have gone for a more reader friendly, simple language so that our subscribers find it easy to completely understand the company and its stock that they plan to Buy/Hold/Sell.

So for you, this is an absolutely unbeatable offer. You definitely can't get any offer better than this.

So through this offer you will get:

  • A 3-month Trial subscription of StockSelect for just Rs 499

  • Our Last 5 Buy Recommendations

  • 12 Buy/Sell/Hold Recommendations

  • Subscribers-only Features

  • Quarterly Performance Updates

  • Access to archives of all the previous issues of StockSelect

  • 30-Day, No-Questions- Asked, 100% Money Back Guarantee

  • Free access to our "intelligent" Portfolio Tracker

  • Free Subscription to The Daily Reckoning

But there is a catch . . .

This offer is valid till 11:59 PM on Thursday, 31st May only!

This is a never-before offer.

And I can almost guarantee you that you will not see this offer ever again!

StockSelect might never be available at a quarterly subscription of Rs 499.

In fact after 11:59 PM on Thursday, 31st May, the price of StockSelect will revert back to Rs 5,000.

You see, the only intention behind this offer is to let you experience the product yourself. We are confident about our research and so are giving it at such a highly discounted price for a short duration.

Plus we are also offering you a 30-day, No-Questions-Asked, 100% Money Back Guarantee. In these 30 days, check out our last 5 buy recommendations, see our new recommendations, access our complete archives, read all our lucrative special reports...

But, what after 3 months?

As soon as you confirm your membership, we will charge your credit card Rs 499 and give you unlimited access to StockSelect for 3 months.

In this period, you can try our service as much as you want...

...Go through all our StockSelect recommendations
...See the special reports available
...Access our archives to see our recommendation and reports

Basically, evaluate the service and see if it meets your expectations or not.

And if you still feel that StockSelect is not for you, then just get in touch with us on or before the 31st day and let us know.

We will immediately cancel your subscription and refund your full amount of Rs 499.

But, honestly, I'm sure that once you see our research, you will definitely like it and would not want to cancel it.

And when you do not cancel your subscription even after 3 months of your Trial Period, we will go ahead and automatically charge your credit card Rs 1,950 as your annual subscription fee for StockSelect at our Lowest Price Ever.

Rest assured your annual subscription will start the day after your 3 months trial period ends.

Yes! Just Rs 1,950 per year instead of the usual Rs 5,000, which is the actual cost of StockSelect.

And you’ll also be locking in your subscription to StockSelect at this low price. In other words, even after you complete your Annual subscription, you will have the option to renew for another year at just Rs 1,950...

This More than 60% discount price is locked-for-life!

Frankly, you cannot get a better offer than this. And the question of repeating this offer just does not arise.

So, sign up for this offer immediately!

This offer will close at 11:59 PM on Thursday, 31st May and there will be no further extensions.

So don't waste another moment...

[Sign up now! Click here]
 

Regards,

Rahul Goel
CEO, Equitymaster

P.S.: This never before offer will be available till 11:59 PM on Thursday, 31st May. After that the price of StockSelect will revert back to Rs 5,000. We can almost guarantee you that you will never find StockSelect at Rs 499 ever again! So Click here and subscribe right away.

P.P.S.: Remember you are entitled to a 30-day money back guarantee on this offer. So sign up and at least see what StockSelect is all about. If you don't like it, we'll give you a FULL refund anyway.

P.P.P.S.: If you have any queries, please do not hesitate to contact us at +91-22-61434055 or Write in to us. We will be delighted to assist you!
Subscribe Now For
Rs 499 Only!


*Returns calculated as on 30th March 2012 or on the date of Sell recommendation, whichever is applicable.
**StockSelect Track Record calculated from 2002 to 2010

Please read the Terms of Use.
Equitymaster Agora Research Private Limited
103, Regent Chambers,
Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-6143 4055